People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zyus Life Sciences Inc. | — | Other Health Care | Series B | $40.4M | $10.4M | 2023 |
Dr. Lionel Marks De Chabris at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dr. Lionel Marks De Chabris on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Knowles | 1 | 4 |
| Brent Zettl | 1 | 4 |
| John Hyshka | 1 | 3 |
| Richard Hoyt | 1 | 3 |
| Keith Carpenter | 1 | 3 |
| Garnette Weber | 1 | 2 |
| Michelle Gursky | 1 | 2 |
| Donald Ching | 1 | 2 |
| Larry Holbrook | 1 | 2 |
| Allan Fowler | 1 | 1 |
| Rob Harding | 1 | 1 |
| Adam Darbellay | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.